NCT02732314View on ClinicalTrials.gov

Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis

PHASE4CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Dermatitis, AtopicEczema
Interventions
DRUG

Investigational OTC Cream

OTHER

Cosmetic Eczema Cream

DRUG

0.05% Desonide Cream

OTHER

Placebo Cream

Trial Locations (1)

27612

Wake Research Associates, LLC, Raleigh

All Listed Sponsors
lead

Procter & Gamble Beauty

INDUSTRY

NCT02732314 - Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis | Biotech Hunter | Biotech Hunter